Thermo Fisher Scientific, Inc. (NYSE:TMO)

273. Thermo Fisher Scientific (NYSE: TMO) has a history of beating their consensus expectations. Their P/E at present looks high but you need to back the outperformance of one quarter last year. Their P/E really is about 10. That's cheap considering that even analyst bearish cases forecast top line revenue growth and EPS estimates holding the line, so to speak. I think that the present valuation is pricing in the analyst worst case scenerio. There is upside here and I think that this one got beat up by tax loss selling last year and the swing up that you've seen so far this year is simply the January effect. Is there more to this beyond just an effect? I think so. Target: $52-$57.

http://beta.fool.com/bradford86/2012/01/13/price-market-part-41/

This is tracking porfortlio of the 20 stock I pick for 2012...

Based on the 5-yr. weighted average of p/e, p/b, p/s, roe, roa the fair value of the company is $57.74. Right now they are trading near their 52 week low since they haven't quite rebounded from the August collapse. Only see an upside to this stock.

IV Best Buy Now

EBITA continues to grow. Supplier for large scientifically community.

key03, no div

S&P 5 star

Over reaction down ... good company ... back to 55

http://research2.fidelity.com/fidelity/research/reports/pdf/getReport.asp?feedID=72&docTag=88355610&verstionTag=3J25FEJLT21UJH8VDDPKDDDDBJ&user_sessionid=AD0BCA9F0BE477126D4D0B2F3E17AB1F

A small adjustment in guidance (.5%) caused an 8% drop. The company still has great fundamentals and this is a good time to buy it at a value price.

I work here

Should easily beat S&P500.

Morningstar 5 star pick and 10 billion stimulus money to be distributed into Life Sciences should benefit TMO.

Thermo-Fisher is the giant of scientific supply companies. If they can manage all the acquisitions from the past couple of years including the attempt to corner the market of siRNA products. Im bullish because of the nice margins they get from so many great suppliers like 5'Prime, GE Healthcare, and BrandTek.

My father worked for this company for a long time as a regional accountant. The management is very intelligent. The company is great top to bottom. My family has over 650 shares invested long term because we know first had the credibility and culture of the company.

Massive repurchase of stock during the first quarter of this year.

The world future depends on creative minds. Thermo has more than it's share. I just believe you can hang your hat on this company and keep it long term. It is dominate in all of the growth areas. As the company matures there will probably be a dividend but don't rush it. I will hold long term. gojoe2

With healthcare and the environment becoming increasingly popular topics (and growth projected in both), a company like TMO which has a hand in them will surely benefit. As creative minds leave finance and begin to drift towards sciences, it's reasonable to expect growth in real US innovation again (rather than the financial trickery and smoke-and-mirrors-"creativity" that led to this recession). Smart minds will have green collar jobs, and jobs in healthcare, and they will need instruments to their jobs. This bodes well for TMO's profits and prospects for growing market presence.

Those who supply the new bio-techs, pharmas, and life science companies will succeed along with them, but with less volatility.